The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is being done to compare the safety and effects (good and bad) of three different combinations of immunosuppression drugs used by kidney transplant recipients while also looking at their kidney function.

• Phase: Phase 4

Details

• Lead Sponsor: Mayo Clinic
• Collaborator: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Everolimus; Sirolimus

Criteria

Participants must be at least between the ages of 18 and 75, and will be receiving their first or second kidney transplant.